U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
108301108301A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisActive, not recruitingNo Results AvailableUveitisDrug: adalimumabhttps://ClinicalTrials.gov/show/NCT01148225
108302108302Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)CompletedNo Results AvailableBest Comfort and Lowest Skin Irritationhttps://ClinicalTrials.gov/show/NCT01148212
108303108303Self-expandable Metallic Stent Versus Multiple Plastic Stents in Post Orthotopic Liver Transplantation Biliary StenosisRecruitingNo Results AvailableBiliary Anastomotic Stenosis|Biliary StrictureDevice: Self-expandable metalic stent|Device: Multiple plastic stentshttps://ClinicalTrials.gov/show/NCT01148199
108304108304An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older AdultsTerminatedNo Results AvailablePolypharmacy|Incontinence|Insomnia|AnxietyBehavioral: knowledge transfer toolhttps://ClinicalTrials.gov/show/NCT01148186
108305108305High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive LymphomasRecruitingNo Results AvailableLymphoma, Non-HodgkinDrug: Combined systemic and intrathecal chemotherapy followed by HD-ASCThttps://ClinicalTrials.gov/show/NCT01148173
108306108306Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic MalignancyTerminatedNo Results AvailableInvasive Fungal InfectionDrug: voriconazolehttps://ClinicalTrials.gov/show/NCT01148160
108307108307Intracoronary Adenosine Administration to Prevent Periprocedural Myonecrosis in Elective Coronary AngioplastyCompletedNo Results AvailableCoronary AngioplastyDrug: Adenosine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01148147
108308108308Pharmacokinetic Profile of Vincristine Administered With Imatinib for Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL) Compared to That Without Imatinib for Bcr-Abl Negative ALLTerminatedNo Results AvailableAcute Lymphoblastic Leukemiahttps://ClinicalTrials.gov/show/NCT01148134
108309108309Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn ModelCompletedNo Results AvailableDown SyndromeGenetic: Skeletal Status Assessment of a Down Syndrome Populationhttps://ClinicalTrials.gov/show/NCT01148121
108310108310Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple MyelomaCompletedNo Results AvailableMantle Cell Lymphoma|B Cell Lymphoma|Multiple MyelomaDrug: Canfosfamide HCl for injectionhttps://ClinicalTrials.gov/show/NCT01148108
108311108311To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy VolunteersCompletedNo Results AvailablePart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years.|Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80Drug: AZD2516|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01148095
108312108312School Response to Families Who Have Children With CancerNot yet recruitingNo Results AvailableCarcinomas|Squamous Cell Carcinoma|AdenocarcinomaProcedure: Self administered Surveys|Procedure: Interviewshttps://ClinicalTrials.gov/show/NCT01148082
108313108313Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate CancersActive, not recruitingNo Results AvailableProstate Cancer|Prostate AdenocarcinomaProcedure: Surgery combined with IMRT-IGRThttps://ClinicalTrials.gov/show/NCT01148069
108314108314Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal CancerTerminatedNo Results AvailableRectal CancerRadiation: Intensity Modulated Radiation Therapyhttps://ClinicalTrials.gov/show/NCT01148056
108315108315Pharmacological Treatment In OsteoarthritisCompletedNo Results AvailableOsteoarthritisDrug: Hydroxychloroquine|Drug: cellulosehttps://ClinicalTrials.gov/show/NCT01148043
108316108316Impact of Pre-surgical Nasal Bacterial Reduction on Postoperative Surgical Site Infections / Standard Care ChangeTerminatedNo Results AvailableSurgical Site InfectionDrug: 3M Skin and Nasal Antiseptichttps://ClinicalTrials.gov/show/NCT01148030
108317108317Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate VaccineCompletedHas ResultsMeningococcal MeningitisBiological: Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccinehttps://ClinicalTrials.gov/show/NCT01148017
108318108318The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy VolunteersCompletedNo Results AvailableHIV|Fenofibrate|Protease Inhibitors|Hypertriglyceridemia|GlucuronosyltransferaseDrug: Fenofibrate|Drug: Ritonavir|Drug: Lopinavir/Ritonavirhttps://ClinicalTrials.gov/show/NCT01148004
108319108319Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related CancerCompletedNo Results AvailableGastric Cancer|Head and Neck Cancer|Lymphoma|Lymphoproliferative Disorder|Nonneoplastic ConditionBiological: EBNA1 C-terminal/LMP2 chimeric protein-expressing recombinant modified vaccinia Ankara vaccine|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT01147991
108320108320Proactive Communication Strategy in Intensive Care Unit and Post Traumatic Stress SymptomsCompletedNo Results AvailableCritically Ill PatientsBehavioral: End of ICU stay conferencehttps://ClinicalTrials.gov/show/NCT01147978
108321108321Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEACompletedNo Results AvailableColon Cancer|Lung Cancer|Breast CancerBiological: AD5 CEA Vaccinehttps://ClinicalTrials.gov/show/NCT01147965
108322108322The Effect of Exercise on Peripheral Blood Gene Expression in AnginaNot yet recruitingNo Results AvailableAngina PectorisBehavioral: Structured exercise traininghttps://ClinicalTrials.gov/show/NCT01147952
108323108323Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)CompletedNo Results AvailableAcute Myeloid Leukemia (AML)Drug: Elacytarabine|Drug: Investigator's Choicehttps://ClinicalTrials.gov/show/NCT01147939
108324108324Evaluation of Prucalopride in Male Subjects With Chronic Constipation.CompletedHas ResultsMale Subjects With Chronic ConstipationDrug: Placebo|Drug: Prucalopridehttps://ClinicalTrials.gov/show/NCT01147926
108325108325Computerized Information-Processing Bias Retraining in Depressed AdolescentsCompletedNo Results AvailableMajor DepressionBehavioral: Computerized Information-Processing Bias Retraining|Behavioral: Attention Control Traininghttps://ClinicalTrials.gov/show/NCT01147913
108326108326Evaluation of Boostrixâ„¢10 Years After Previous Booster VaccinationCompletedHas ResultsAcellular Pertussis|Tetanus|DiphtheriaBiological: Boostrixâ„¢|Biological: Boostrixâ„¢-US formulationhttps://ClinicalTrials.gov/show/NCT01147900
108327108327A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Drug combination/ 26489112https://ClinicalTrials.gov/show/NCT01147887
108328108328Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology PracticeCompletedHas ResultsPsoriasis|Psoriatic ArthritisProcedure: lab draws and imaginghttps://ClinicalTrials.gov/show/NCT01147874
108329108329A Phase 1 Study to Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 DiabeticsCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: GSK256073|Drug: GSK256073|Drug: GSK256073|Drug: GSK256073|Other: Placebohttps://ClinicalTrials.gov/show/NCT01147861
108330108330HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsCompletedHas ResultsAsthmaDrug: Fluticasone furoate/Vilanterol Inhalation Powder|Drug: Fluticasone propionate/salmeterol Inhalation Powder|Drug: Placebo (1)|Drug: Placebo (2)https://ClinicalTrials.gov/show/NCT01147848

* Görseller ve İçerik tekif hakkına sahip olabilir